The Power of Touch: How Physical Contact Can Reshape the Clinical Exam — Part 1
What is the power of touch and how has it played into the history of clinical treatment as well as our current reality?
Treatments
Some Patients Respond Immediately to Capsaicin Patch While Others Require Multiple Treatments
This objective of this study was to investigate the efficacy of repeated application of capsaicin cutaneous patches in those who did not respond to the first application.
Sevuparin Does Not Reduce Duration of Vaso-Occlusive Crisis in Patients with Sickle Cell Disease
In this study, the researchers tested whether sevuparin could shorten vaso-occlusive crisis duration in hospitalized patients with sickle cell disease.
Study Finds Small Association Between Type 2 Diabetes Drugs and COVID-19-Related Mortality
The researchers investigated whether there are associations between different classes of glucose-lowering drugs and risk of COVID-19-related mortality in people with type 2 diabetes.
NICE Releases New UK Guideline for Assessment and Management of Chronic Pain
This guideline, developed in partnership with the Royal College of Physicians, is aimed at health care professionals, commissioners, and providers of services; people with chronic primary or secondary pain; and the families of chronic pain patients.
Phenotypic Stratification of Patients With Painful Neuropathy May Predict Response to Therapy
The researchers’ objective was to compare the classification of patients with that reported in a recent study by identifying 3 clusters of patients with different sensory profiles.
Better Benefit-to-Risk Ratio for Anti-CGRP mAbs Than Current Migraine Preventive Medication
The researchers compared anti-CGRP mAbs with other drugs for the prevention of episodic and chronic migraine using a likelihood to help versus harm analysis.
Active Occipital Nerve Stimulation May Reduce Aversive Effects of Chronic Migraine
This study’s main goal was to investigate how ONS acts on patients’ protective mechanisms and pain-defending protective reflexes.
Ascorbic Acid and Zinc Gluconate Do Not Improve COVID-19 Symptoms
Study authors examined the effect of high-dose zinc and/or ascorbic acid on the severity or reduction of SARS-CoV-2 duration compared with the standard of care.
FDA Panel Says Experimental Arthritis Drug Too Risky
An FDA advisory panel says a Pfizer experimental arthritis drug is too risky to approve.
-
Loading...
-
Loading...
Next post in Musculoskeletal Pain
